Lake BG et al. |
Inhibition of xenobiotic-induced genotoxicity in cultured precision-cut human and rat liver slices. |
1999 |
Mutat. Res. |
pmid:10095132
|
Rooprai HK et al. |
Influence of putative antiinvasive agents on matrix metalloproteinase secretion by human neoplastic glia in vitro. |
1999 |
Ann. N. Y. Acad. Sci. |
pmid:10415799
|
Bracke ME et al. |
Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer. |
1999 |
J. Natl. Cancer Inst. |
pmid:10050869
|
Breinholt V et al. |
Differential effects of dietary flavonoids on drug metabolizing and antioxidant enzymes in female rat. |
1999 |
Xenobiotica |
pmid:10647909
|
Nielsen SE et al. |
Biotransformation of the citrus flavone tangeretin in rats. Identification of metabolites with intact flavane nucleus. |
2000 |
Food Chem. Toxicol. |
pmid:10930694
|
Takanaga H et al. |
Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10734174
|
Guo XL et al. |
[Studies on chemical constituents of processed green tangerine peel]. |
2000 |
Zhongguo Zhong Yao Za Zhi |
pmid:12212096
|
Backman JT et al. |
Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation. |
2000 |
Clin. Pharmacol. Ther. |
pmid:10801247
|
Depypere HT et al. |
Inhibition of tamoxifen's therapeutic benefit by tangeretin in mammary cancer. |
2000 |
Eur. J. Cancer |
pmid:11056327
|
Ikegawa T et al. |
Inhibition of P-glycoprotein by orange juice components, polymethoxyflavones in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells. |
2000 |
Cancer Lett. |
pmid:11098080
|
Siess MH et al. |
Mechanisms involved in the chemoprevention of flavonoids. |
2000 |
Biofactors |
pmid:11216486
|
Rong H et al. |
8-Prenylnaringenin, the phytoestrogen in hops and beer, upregulates the function of the E-cadherin/catenin complex in human mammary carcinoma cells. |
2001 |
Eur. J. Cell Biol. |
pmid:11675933
|
Datla KP et al. |
Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease. |
2001 |
Neuroreport |
pmid:11726811
|
Rooprai HK et al. |
Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro. |
2001 |
Neuropathol. Appl. Neurobiol. |
pmid:11299000
|
Delaney B et al. |
Immunotoxicity of a standardized citrus polymethoxylated flavone extract. |
2001 |
Food Chem. Toxicol. |
pmid:11527568
|
Williams JA et al. |
Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes. |
2002 |
Drug Metab. Dispos. |
pmid:12386134
|
Wang MS et al. |
Inhibition of 11beta-hydroxysteroid dehydrogenase in guinea pig kidney by three bioflavonoids and their interactions with gossypol. |
2002 |
Acta Pharmacol. Sin. |
pmid:11860745
|
Brack ME et al. |
The citrus methoxyflavone tangeretin affects human cell-cell interactions. |
2002 |
Adv. Exp. Med. Biol. |
pmid:12083457
|
Pan MH et al. |
Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. |
2002 |
Carcinogenesis |
pmid:12376477
|
Delaney B et al. |
Genetic toxicity of a standardized mixture of citrus polymethoxylated flavones. |
2002 |
Food Chem. Toxicol. |
pmid:11955667
|